
Hovione has over 55 year of experience as a CDMO and is currently a fully integrated supplier offering from drug substance to drug product intermediate to drug product. With four FDA-inspected sites in the US, Ireland, Portugal, and China and development laboratories in Portugal and the US, Hovione provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds. Hovione employs 1,900 people worldwide and has more than 1300m3 of flexible production capacity. Click here for more.